Literature DB >> 2050317

Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report.

E M Brunt1, H White, J W Marsh, B Holtmann, M G Peters.   

Abstract

A previously healthy but obese 26-yr-old woman was diagnosed as having hepatic dysfunction 17 days after the third of three consecutive exposures to isoflurane anesthesia for paranasal sinus surgery. Serum laboratory findings included elevated aminotransferases and bilirubin. Radiographical evaluations showed no evidence of extrahepatic disease. Serological studies were negative for acute viral infections, and serum copper was normal. The patient's condition deteriorated over the ensuing 17 days, with hyperreflexia, hypoglycemia and a rapid fall in serum aminotransferases with a concomitant rise in bilirubin level and prothrombin time despite maximal medical support. The liver volume as shown by computed tomography fell from 1,290 cm3 to 680 cm3 over 6 days. The patient underwent successful orthotopic liver transplantation 25 days after onset of symptoms. Histopathological examination of the resected liver showed submassive and massive necrosis, with a few foci of microvesicular steatosis and ultrastructural evidence of mitochondrial abnormalities. Although we found insufficient evidence to prove that this case was caused by isoflurane anesthesia, the clinical course and histopathological findings are similar to those in hepatic injury caused by halothane anesthesia. Therefore we report this as a possible case of fulminant hepatic failure resulting from isoflurane anesthesia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050317

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  [New technical developments for inhaled sedation].

Authors:  A Meiser; H Bomberg; T Volk; H V Groesdonk
Journal:  Anaesthesist       Date:  2017-04       Impact factor: 1.041

2.  Differential diagnosis of postoperative liver failure in a 12-year-old child.

Authors:  R Hausmann; B Schmidt; B Schellmann; P Betz
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

3.  Isoflurane anesthesia induces liver injury by regulating the expression of insulin-like growth factor 1.

Authors:  Yingxian Zhu; Xiaoyu Xiao; Guowei Li; Juyuan Bu; Wenying Zhou; Shaopeng Zhou
Journal:  Exp Ther Med       Date:  2017-02-22       Impact factor: 2.447

4.  Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments.

Authors:  Charles M Skinner; Isabelle R Miousse; Laura E Ewing; Vijayalakshmi Sridharan; Maohua Cao; Haixia Lin; D Keith Williams; Bharathi Avula; Saqlain Haider; Amar G Chittiboyina; Ikhlas A Khan; Mahmoud A ElSohly; Marjan Boerma; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2018-09-30       Impact factor: 6.023

5.  Fulminant hepatic failure after repeated exposure to isoflurane.

Authors:  Halemani R Kusuma; Neelam K Venkataramana; Shailesh Av Rao; Arun L Naik; Ds Gangadhara; Keshavan H Venkatesh
Journal:  Indian J Anaesth       Date:  2011-05

6.  Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.

Authors:  Julie Massart; Karima Begriche; Caroline Moreau; Bernard Fromenty
Journal:  J Clin Transl Res       Date:  2017-02-12

7.  Effects of repeat exposure to inhalation anesthetics on liver and renal function.

Authors:  Tomoki Nishiyama
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-01

8.  Volatile anesthetics in ischemic liver injury: enemy or friend?

Authors:  Masood Mohseni; Saeid Safari; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-06-01       Impact factor: 0.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.